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1. Introduction 
Natural estrogens have a wide array of biological actions not only on the female 
reproductive system but also on metabolic homeostasis, cell proliferation and 
differentiation. The long-term genomic effects of estrogens are known to be mediated 
through classical nuclear receptors such as estrogen receptor-ǂ (ER-ǂ) and -ǃ (ER-ǃ) (Green 
et al., 1986; Krust et al., 1986; Mosselman et al., 1996). In addition to this established 
mechanism of action, much evidence has been accumulated that estrogens also have non-
genomic actions via the activation of plasma membrane estrogen receptors (Wehling 1997; 
Falkenstein et al., 2000). Indeed, the cell membrane estrogen receptors have been extensively 
studied, resulting in the identification of several types of membrane estrogen receptors, such 
as ER-ǂ, its S-palmitoylated ER variant (Li et al., 2003; Wyckoff et al., 2001), ER-X (Toran-
Allerand et al., 2002; Qui et al., 2006), and GPR30 (Thomas et al., 2005; Revankar et al., 2005). 
Among these, GPR30 may be the most plausible candidate for a membrane estrogen 
receptor that regulates the various functions induced by estrogens (Funakoshi et al., 2006; 
Filardo et al., 2007), although the precise cellular localization and functions of GPR30 remain 
controversial (for review see, Mizukami 2010). 
Soybeans have traditionally been consumed as food, especially in East Asian countries. 
Isoflavones such as daidzein and genistein are soy phytoestrogens and have a weak 
estrogenic activity due to the fact that their structures are similar to the primary structure of 
estrogens (Kurzer and Xu, 1997). Recent research attention has been paid to the high dietary 
intake of isoflavones because of their potentially beneficial effects associated with a 
reduction in the risk of developing cardiovascular diseases (Arjmandi et al., 1997), 
osteoporosis (Adlercreutz et al., 1993; Toda et al., 1999), menopausal symptoms (Adlercreutz 
et al., 1992), and some forms of cancers (Messina et al., 1994). These effects are considered to 
be mediated by binding to the nuclear estrogen receptors (Kurzer and Xu, 1997; Murkies et 
al., 1998).  
Adrenal medullary cells are derived from the embryonic neural crest and share many 
properties with sympathetic postganglionic neurons. In cultured bovine adrenal medullary 
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cells, our previous studies have shown that carbachol, a derivative of acetylcholine, induced 
22Na+ influx via voltage-dependent Na+ channels, and then increased 45Ca2+ influx via 
voltage-dependent Ca2+ channels, a prerequisite for secretion (Wada et al., 1985; Yanagihara 
et al., 1996) and synthesis (Yanagihara et al., 1987) of catecholamines. Since the mechanism 
of stimulation of catecholamine synthesis and secretion in adrenal medullary cells are 
thought to be similar to those of noradrenaline in the sympathetic neurons, adrenal 
medullary cells have provided a good model for detailed analysis of the actions of 
cardiovascular drugs, such as ǂ2-adrenergic agonists (Yanagihara et al., 1987), natriuretic 
peptides (Yanagihara et al., 1991), carvedilol (Kajiwara et al., 2002) and pimobendan 
(Toyohira et al., 2005).  
In our previous studies, treatment of bovine adrenal medullary cells with environmental 
estrogenic pollutants such as p-nonylphenol and bisphenol A stimulated catecholamine 
synthesis and tyrosine hydroxylase activity, probably through plasma membrane estrogen 
receptors (Yanagihara et al., 2005). Indeed, we demonstrated the occurrence and functional 
roles of unique estrogen receptors in the plasma membranes isolated from bovine adrenal 
medullary cells (Yanagihara et al., 2006). 17ǃ-Estradiol stimulated catecholamine synthesis 
via activation of extracellular signal-regulated kinases (ERKs) through the plasma 
membrane estrogen receptors.  
The present review summarizes the current knowledge of pharmacological effects of 
daidzein and genistein on catecholamine signaling, such as catecholamine synthesis and 
secretion in cultured bovine adrenal medullary cells and noradrenaline reuptake by SK-N-
SH cells and by COS-7 cells transiently transfected with noradrenaline transporter. 
2. Dual effects of daidzein on catecholamine synthesis and secretion 
Incubation of bovine adrenal medullary cells with daidzein for 20 min resulted in a small 
increase in 14C-catecholamine synthesis from [14C]tyrosine (Fig. 1A). The stimulatory effect of 
daidzein on 14C-catecholamine synthesis was observed to be concentration-dependent (10-1000 
nM). Daidzein inhibited the specific binding of [3H]17ǃ-estradiol in a concentration (10-1000 
nM)-dependent manner (Fig. 1B) similar to that of 14C-catecholamine synthesis. From these 
results, it is likely that daidzein stimulates catecholamine synthesis via activation of membrane 
estrogen receptors in bovine adrenal medullary cells. Previous studies have shown that the 
serum concentrations of daidzein are around 200-350 nM in Japanese people older than 40 
years (Morton et al., 2002) and that the serum levels of daidzein in humans consuming three 
meals per day, including one meal containing soybeans, can reach a maximum of 4.1 μM (King 
and Bursill, 1998). It seems that the concentrations of daidzein used in the present study are 
relevant in people’s daily lives because these concentrations partially overlap with those in the 
plasma of individuals who consume soy products. 
Daidzein (1 μM) and acetylcholine (0.3 mM) increased 14C-catecholamine synthesis form 
[14C]tyrosine by 31% and 245% over the control levels, respectively (Fig. 2A). Concurrent 
treatment of cells with daidzein and acetylcholine did not enhance but significantly inhibited 
the stimulatory effect of acetylcholine on 14C-catecholamine synthesis (84% of acetylcholine). 
To determine which step of catecholamine synthesis was enhanced by daidzein, [14C]DOPA 
was used as a substrate instead of [14C]tyrosine (Fig. 2B). Neither daidzein nor acetylcholine 
increased 14C-catecholamine synthesis from [14C]DOPA, suggesting that the increase in 
catecholamine synthesis induced by daidzein and acetylcholine occurs predominantly 
upstream of the DOPA decarboxylase step, i.e., tyrosine hydroxylase step. Indeed, incubation 
of cells with daidzein (1 μM) for 10 min resulted in a significant increase in tyrosine 
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hydroxylase activity of 27% over the control (Fig. 3B). ICI182,780 (100 nM), an inhibitor of 
nuclear estrogen receptors when used alone, increased 14C-catecholamine synthesis as well as 
tyrosine hydroxylase activity, and did not abolish but rather enhanced both stimulatory effects 
of daidzein (Fig. 3A and B). Furthermore, ICI182,780 enhanced the specific binding of [3H]17ǃ-
estradiol to plasma membranes isolated from bovine adrenal medulla (data not presented). 
This gives rise to the possibility that daidzein and ICI182,780 act synergistically on different 
sites of the membrane estrogen receptors. 
 
 
Fig. 1. Concentration–response curve of daidzein for 14C-catecholamine synthesis from 
[14C]tyrosine in cultured bovine adrenal medullary cells (A) and concentration-inhibition 
curve for specific binding of [3H] 17ǃ-estradiol to adrenal medullary plasma membranes (B). 
(A) Cultured bovine adrenal medullary cells (4x106 /dish) were incubated with (●) or 
without (○) various concentrations (1 – 1000 nM) of daidzein at 37 °C for 20 min in 1.0 ml 
KRP buffer containing L-[U-14C]tyrosine (20 μM, 1 μCi). The 14C-labeled catecholamines 
formed are measured and shown as the total 14C-catecholamines (adrenaline, noradrenaline 
and dopamine). Date are expressed as the mean ± SEM of four experiments carried out in 
duplicate. *p < 0.05 and **p < 0.01, compared with control. (B) Plasma membranes isolated 
form bovine adrenal medulla were incubated at 4 °C for 30 min with various concentrations 
of daidzein in the presence of [3H]17ǃ-estradiol (5 nM, 0.1 μCi). Non-specific binding was 
determined in the presence 1 μM of 17ǃ-estradiol and specific binding was obtained by 
subtracting non-specific binding from total binding. Values shown are means ± SEM of four 
separate experiments carried out in triplicate. *p < 0.05 and **p < 0.01, compared with 
control. Data from Liu et al. (2007) are modified. 
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Fig. 2. Effects of daidzein on 14C-catecholamine synthesis from [14C]tyrosine (A) or 
[14C]DOPA (B). The cells (4 x106/dish) were incubated with or without daidzein (1 μM) and 
acetylcholine (ACh)(0.3 mM) at 37 ˚C for 20 min or 15 min in the presence of L-[U-
14C]tyrosine (20 μM, 1 μCi) (A) or [14C]DOPA (20 μM, 0.25 μCi) (B), respectively. The 14C-
catecholamines formed were measured. Data are expressed as the mean ± SEM of four 
experiments carried out in triplicate. *p < 0.05 and **p < 0.01, compared with control; ***p 
< 0.05, compared with acetylcholine alone. Data from Liu et al. (2007) are modified.  
We next studied the effect of daidzein on catecholamine secretion induced by acetylcholine. 
The catecholamine secretion induced by acetylcholine corresponded to 13.5% of the total 
catecholamine content in the cells. Daidzein (1, 10, and 100 μM) significantly suppressed 
catecholamine secretion induced by acetylcholine to 94%, 88%, and 64% of that by 
acetylcholine alone (Fig. 4), respectively. These findings suggest that daidzein has dual 
effects on catecholamine synthesis and secretion, i.e., at low concentrations (10-100 nM) 
daidzein activates tyrosine hydroxylase activity and stimulates catecholamine synthesis, but 
at high concentrations (≧1 μM) it attenuates catecholamine synthesis and secretion induced 
by acetylcholine. 
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Fig. 3. Effects of daidzein and/or ICI182,780, an inhibitor of classical nuclear estrogen 
receptors, on 14C-catecholamine synthesis (A) and tyrosine hydroxylase activity (B). (A) The 
cells (4x106/dish) were incubated with or without daidzein (DZ) (1 μM) and/or ICI182,780 
(ICI) (100 nM) at 37 °C for 20 min in the presence of L-[U-14C]tyrosine. Data are expressed as 
the means ± SEM of four experiments carried out in triplicate. *p < 0.05, compared with 
control; **p < 0.05, compared with daidzein alone. (B) Cells (106/well) were preincubated in 
250 μl of KRP buffer with or without (1 μM) daidzein and/or ICI182,780 (100 nM) for 10 min 
and then incubated for another 10 min in the presence of L-[1-14C]tyrosine (18 μM, 0.2 μCi), 
and tyrosine hydroxylase activity was measured. Data are the mean ± SEM of four separate 
experiments carried out in triplicate. *p < 0.05 and **p < 0.01, compared with control; ***p < 
0.05, compared with daidzein. Data from Liu et al. (2007) are modified. 
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Fig. 4. Effects of daidzein on catecholamine secretion induced by acetylcholine in bovine 
adrenal medullary cells. Cells (2x106/dish) were incubated with acetylcholine (0.3 mM) in 
the presence (●) or absence (○) of various concentrations (0.1-100 μM) of daidzein for 10 min 
at 37 °C. Catecholamines secreted into the medium were measured, and expressed as 
percentage of total catecholamines. Data are means ± SEM of four experiments carried out in 
duplicate. *p <0.05, compared with control (0 μM daidzein). Data from Liu et al. (2007) are 
modified. 
3. Up-regulation of noradrenaline transporter function by genistein 
Treatment of SK-N-SH cells (a human neuroblastoma cell line) with genistein, another soy 
isoflavone, for 20 min stimulated [3H]noradrenaline uptake by the cells in a bell-shaped 
concentration-dependent manner (0.1-10 μM), whereas neither daidzein nor cumestrol, 
another phytoestrogen, did so (Fig. 5A). Genistein (0.01-10 μM) also stimulated 
[3H]noradrenaline uptake by COS-7 cells transiently transfected with noradrenaline 
transporter  (Fig.5B). In Japanese middle-aged women, the dietary intake of genistein was 
reported to be 111.6 μmol/day/capita (30.1 mg/day/capita), and the median plasma 
concentration of genistein was 206 nM (Arai et al., 2000). Since Asian individuals generally 
consume more soy foods than do people in developed Western countries, the mean 
concentrations of genistein in Japanese and UK men were 493 nM and 33 nM, respectively 
(Morton et al., 2002). Furthermore, a previous paper (Adlercreutz et al., 1993) reported that 
the plasma concentration of genistein exceeded 2400 nM in one Japanese man.  Therefore, it 
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seems that the genistein concentrations used in the present study are nutritionally (or 




Fig. 5. Effects of various phytoestrogens on [3H]noradrenaline uptake by SK-N-SH cells (A) 
and COS-7 cells transfected with bovine noradrenaline transporters (B). (A) SK-N-SH cells 
were pretreated for 20 min with or without various concentrations (0.01 – 100 μ M) of 
genistein (●), daidzein (■), or coumestrol (▲), and then incubated for another 10 min with 
[3H]noradrenaline (0.1 μM, 0.1 μCi) in the presence or absence of phytoestrogens (0.01 - 100 
μM). Results are presented as percentage of control values (62.3 ± 4.2 fmol/106 cells/min). 
Data are means ± SEM from three separate experiments. *p < 0.05, compared with control. 
(B) The bovine noradrenaline transporter transfected COS-7 cells were pretreated for 20 min 
with various concentrations of genistein (0.01 – 100 μM), and then the desipramine-sensitive 
uptake of [3H] noradrenaline by the cells was measured. *p < 0.05, compared with control. 
Data from Toyohira et al. (2010) are modified. 
From Eadie-Hofstee analysis of [3H] noradrenaline uptake, genistein (10 μM) caused a 
significant increase in the maximal velocity (Vmax) of noradrenaline transport with little 
change in the Michealis-Menten constant (Km) value (Fig. 6A). Scatchard analysis of 
[3H]nisoxetine binding to COS-7 cells transiently transfected with noradrenaline transporter 
showed that genistein increases the maximal binding (Bmax) without any change in the 
dissociation constant (Kd) (Fig. 6B).  
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Fig. 6. Eadie-Hofstee plots of [3H] noradrenaline uptake (A) and Scatchard plots of specific 
[3H]nisoxetine binding (B) in bovine noradrenaline transporter transfected COS-7 cells. (A) 
Cells were pretreated with or without genistein (10 μM) for 20 min at 37 ˚C. Desipramine-
sensitive [3H] noradrenaline uptake was measured with various concentrations (0.1 - 10 μM) 
of [3H] noradrenaline and analyzed by Eadie-Hofstee method of [3H] noradrenaline uptake. 
Data are means ± SEM from three separate experiments. Inset: Vmax and Km values were 
calculated by Eadie-Hofstee analysis of the saturation curves in the absence (control) or 
presence of 10 μM genistein. *p < 0.05, compared with control. (B) The bovine noradrenaline 
transporter transfected COS-7 cells were incubated with increasing concentrations of 
[3H]nisoxetine (1 - 24 nM) in the presence or absence of genistein (10 μM) at 4 ˚C for 2 h. 
Non-specific binding was determined in the presence of 10 μM nisoxetine. The specific 
binding was 30-40% of the total binding at the Kd concentration of [3H]nisoxetine. The data 
are plotted by Scatchard plot analysis of the saturation curves of [3H]nisoxetine specific 
binding in the absence (control) or presence of 10 μM genistein. Data are means ± SEM from 
three separate experiments. *p < 0.05, compared with control. Data from Toyohira et al. 
(2010) are modified. 
To test the involvement of nuclear estrogen receptors (ER-ǂ and ER-ǃ) in the stimulatory 
effect of genistein on noradrenaline transport, we used ICI182,780, an inhibitor of both ER-ǂ 
and ER-ǃ. COS-7 cells transfected with noradrenaline transporters were preincubated with 
ICI182,780 (100 nM), and then incubated for another 10 min with [3H]noradrenaline in the 
presence or absence of genistein (100 nM) or 17ǃ-estradiol (100 nM). ICI182,780 by itself 
stimulated [3H]noradrenaline uptake by the cells (data not presented). ICI182,780 did not 
suppress but rather enhanced genistein-induced [3H]noradrenaline uptake. Sodium 
orthovanadate (50 μM), an inhibitor of protein tyrosine phosphatase, significantly inhibited 
[3H]noradrenaline uptake (data not shown). Although genistein is known to be an inhibitor 
of tyrosine kinases, daidzein, an inactive analogue of genistein against tyrosine kinase, had 
little effect on [3H]noradrenaline uptake by SK-N-SH cells (Fig. 5A), suggesting an 
involvement of tyrosine kinase, but not of membrane estrogen receptors. Furthermore, the 
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stimulatory effects on [3H]noradrenaline uptake were observed by treatment with 
tyrophostin 25, an inhibitor of epidermal growth factor receptor tyrosine kinase (Fig. 7A), 
whereas PP2, an inhibitor of the soluble-type src-family of tyrosine kinases, did not affect it 
(Fig. 7B). From these findings, it is suggested that genistein increases the activity of 
noradrenaline transporter, probably through processes involving receptor-type protein 
tyrosine phosphorylation.  
 
 
Fig. 7. Effects of tyrphostin 25 (A) or PP2 (B) on [3H] noradrenaline uptake by COS-7 cells 
transfected with bovine noradrenaline transporters. The bovine noradrenaline transporter 
transfected COS-7 cells were pretreated for 20 min with tyrphostin 25 (0.01 – 100 μM) (A) or 
PP2 (0.001 – 10 μM) (B), and then the desipramine-sensitive uptake of [3H] noradrenaline by 
the cells was measured. Results are presented as percentage of control values. Data are 
means ± SEM from three separate experiments. *p < 0.05, compared with control. Data from 
Toyohira et al. (2010) are modified. 
4. Pharmacological significance of soy isoflavone’s effects on catecholamine 
system 
Soy isoflavones (daidzein and genistein) are present at high concentrations as a glycoside in 
many soybeans and soy foods such as miso, tofu, and soy milk. Several lines of 
accumulating evidence have indicated that soy isoflavones play a role in the prevention of 
cardiovascular diseases, reproductive cancers, and menopausal symptoms (Potter et al., 
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1998; Cassidy et al., 1999; Upmalis et al., 2000; Ishimi et al., 1999). The cardioprotective 
ability of these isoflavones has been attributed partially to their ability to lower cholesterol 
(Wong et al., 1998; Yamakoshi et al., 2000) and cardiovascular disease risk (Lichtenstein 
1998). In the present review, daidzein (0.01-1.0 μM) stimulated catecholamine synthesis by 
20~30% over the control, suggesting that daidzein at nutritionally relevant concentrations 
strengthens the catecholamine system in the adrenal medulla and probably in the 
sympathetic neurons.  
On the other hand, daidzein at high concentrations (over 1.0 μM) suppresses catecholamine 
synthesis and secretion induced by the physiological secretagogue acetylcholine, suggesting 
that daidzein attenuates the catecholamine synthesis and secretion induced by stress and 
emotional excitation, thus causing the stimulation of sympathetic nerves and the adrenal 
medulla. Genistein up-regulates the noradrenaline transporter function. This suggests that 
genistein also stimulates the termination of neurotransmission by the reuptake of 
noradrenaline released into the extracellular milieu and suppresses the sympathetic nerve 
activity. Although catecholamines play a pivotal role in the regulation of normal functions 
in cardiovascular systems, prolonged stress-induced over-expression of endogenous 
catecholamines may contribute to the involvement and augmentation of cardiovascular 
diseases such as heart failure, atherosclerosis, coronary heart disease, and hypertension. 
Indeed, chronic heart failure is associated with activation of the sympathetic nervous system 
as manifested by increased circulating catecholamines and increased regional activity of the 
sympathetic nervous system (Freedman and Lefkowitz, 2004; Westfall and Westfall 2005). 
Furthermore, it has been shown that up-regulation of adrenal medullary G protein-coupled 
receptor kinase 2 is a very important mechanism for mediating the sympathetic 
hyperactivity and circulating catecholamine levels that accompany and aggravate chronic 
heart failure (Lymperopoulos et al., 2007). The present findings on the effects of daidzein 
and genistein in catecholamine system may partially explain the cardiovascular protective 
effects of soy isoflavones. 
5. Future perspectives  
What are the major pending problems or questions revealed by the present study? While the 
in vitro effects of soy isoflavone have been well clarified using cultured bovine adrenal 
medullary cells, SK-N-SH cells or COS-7 cells transiently transfected with noradrenaline 
transporter, the in vivo effects are not as clear. Therefore, to confirm the effects of soy 
isoflavone on catecholamine synthesis, secretion and reuptake, further in vivo studies on the 
effects of administration of daidzein and genistein to animals or humans will be needed in 
the near future.  
Finally, a question arises as to how best to demonstrate the protective effects of soy 
isoflavone on stress-induced catecholamine synthesis and secretoin? The anti-depressive or 
anxiolytic effects of soy isoflavone should be examined using laboratory animals under 
various stress conditions. Analysis with in vivo studies will provide more conclusive 
information and add new pharmacological actions of soy isoflavone on catecholamine 
signaling. 
6. Concluding remarks  
Daidzein and genistein are major natural phytoestrogens found in soybeans. In the present 
review, we have demonstrated that daidzein stimulates catecholamine synthesis at low 
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concentrations similar to those at which daidzein inhibits the specific binding of [3H]17ǃ-
estradiol to the membrane receptors, suggesting that daidzein at low concentrations 
enhances catecholamine synthesis probably through plasma membrane estrogen receptors 
(Liu et al., 2007). However, daidzein at high concentrations (1-100 μM) inhibited 
catecholamine synthesis and secretion induced by acetylcholine, the physiological 
secretagogue. The latter findings suggest that daidzein at high concentrations suppresses 
the catecholamine synthesis and secretion induced by stress or emotional excitation that 
induces the stimulation of the splanchnic nerves and subsequently the adrenal medulla. In 
addition to daidzein’s effects, genistein also increases the activity of the noradrenaline 
transporter, suggesting an enhancement of termination of noradrenaline transmission at the 
sympathetic nerve terminals. Although endogenous catecholamines play an important role 
in the regulation of normal functions in the cardiovascular system, stress-induced over 
expression of catecholamines may contribute to the involvement and augmentation of 
cardiovascular disorders The present findings would support the idea that soy isoflavone 
suppress excessive stress-induced hyperactivity of the sympatho-adrenal system and 
thereby protect the cardiovascular system (Yanagihara et al., 2008). 
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